BNY Mellon Opportunistic Small Cap Fund HCAT Holdings History
BNY Mellon Opportunistic Small Cap Fund's Health Catalyst Inc Holding Summary
As of 2025-02-28, BNY Mellon Advantage Funds, Inc. held - shares of Health Catalyst Inc(HCAT), totaling N/A. This investment constitutes 0% of their stock portfolio, and BNY Mellon Advantage Funds, Inc. now holds 0% of the outstanding Health Catalyst Inc(HCAT) stock.
The initial trade took place in 2020Q2. And since then BNY Mellon Opportunistic Small Cap Fund has made 4 purchases of HCAT, at an average price of $16.31, for a total of 668,231.00 shares. In addition, there have been 10 sales at an average price of $12.01 for 668,231.00 shares. Based on historical transaction data and HCAT's current price of $3.87, BNY Mellon Opportunistic Small Cap Fund's estimated gain on his HCAT holdings is $-2.88 Mil, reflecting a -26.39% gain to date.
BNY Mellon Opportunistic Small Cap Fund HCAT ($3.87) Holding Chart
BNY Mellon Opportunistic Small Cap Fund HCAT ($3.87) Quarterly Buys and Sells
Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
---|---|---|---|---|
Shares Bought | 0 | Average Price $-/Share | ||
Shares Sold | 0 | Average Price $-/Share | ||
Current Price $0.00 | Total Estimated Gain 0 % |
Top Ranked Articles
- 1